Gene · 2053
Papers2,484
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,484
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Novel immune cross-talk between inflammatory bowel disease and IgA nephropathy. | Ren Fail | 2024 | 38628140 | PubTator, text mining | PubMed |
| Characterization and validation of fatty acid metabolism-related genes predicting prognosis, immune infiltration, and drug sensitivity in endometrial cancer. | Biotechnol Appl Biochem | 2024 | 38616327 | PubTator, text mining | PubMed |
| Attenuation of Polycyclic Aromatic Hydrocarbon (PAH)-Induced Carcinogenesis and Tumorigenesis by Omega-3 Fatty Acids in Mice In Vivo. | Int J Mol Sci | 2024 | 38612589 | PubTator, text mining | PubMed |
| The interplay of inflammation and placenta in maternal diabetes: insights into Hofbauer cell expression patterns. | Front Immunol | 2024 | 38590527 | PubTator, text mining | PubMed |
| Cardioprotective response and senescence in aged sEH null female mice exposed to LPS. | Am J Physiol Heart Circ Physiol | 2024 | 38578240 | PubTator, text mining | PubMed |
| Inhibition of soluble epoxide hydrolase as a therapeutic approach for blood-brain barrier dysfunction. | Biochimie | 2024 | 38531484 | PubTator, text mining | PubMed |
| Inhibiting Soluble Epoxide Hydrolase Suppresses NF-κB p65 Signaling and Reduces CXCL10 Expression as a Potential Therapeutic Target in Hashimoto's Thyroiditis. | J Clin Endocrinol Metab | 2024 | 38478377 | PubTator, text mining | PubMed |
| Discovery of the sEH Inhibitor Epoxykynin as a Potent Kynurenine Pathway Modulator. | J Med Chem | 2024 | 38470246 | PubTator, text mining | PubMed |
| Association between CYP4A11 and EPHX2 genetic polymorphisms and chronic kidney disease progression in hypertensive patients. | Nefrologia (Engl Ed) | 2024 | 38448299 | PubTator, text mining | PubMed |
| Regulation of soluble epoxide hydrolase in renal-associated diseases: insights from potential mechanisms to clinical researches. | Front Endocrinol (Lausanne) | 2024 | 38425758 | PubTator, text mining | PubMed |
| ALDH2 is a novel biomarker and exerts an inhibitory effect on melanoma. | Sci Rep | 2024 | 38378847 | PubTator, text mining | PubMed |
| A prognostic metabolism-related gene signature associated with the tumor immune microenvironment in neuroblastoma. | Am J Cancer Res | 2024 | 38323276 | PubTator, text mining | PubMed |
| Evolution of chemistry and selection technology for DNA-encoded library. | Acta Pharm Sin B | 2024 | 38322331 | PubTator, text mining | PubMed |
| Establishment and validation of a novel peroxisome-related gene prognostic risk model in kidney clear cell carcinoma. | BMC Urol | 2024 | 38297313 | PubTator, text mining | PubMed |
| Antioxidant Genes Variants and Their Association with Sperm DNA Fragmentation. | Biochem Genet | 2024 | 38294591 | PubTator, text mining | PubMed |
| Comprehensive transcriptomic profiling of liver cancer identifies that histone and PTEN are major regulators of SCU‑induced antitumor activity. | Oncol Lett | 2024 | 38288037 | PubTator, text mining | PubMed |
| Inhibition of soluble epoxide hydrolase enhances the dentin-pulp complex regeneration mediated by crosstalk between vascular endothelial cells and dental pulp stem cells. | J Transl Med | 2024 | 38229161 | PubTator, text mining | PubMed |
| Discovery of a novel lead characterized by a stilbene-extended scaffold against sepsis as soluble epoxide hydrolase inhibitors. | Eur J Med Chem | 2024 | 38215588 | PubTator, text mining | PubMed |
| Drug targets regulate systemic metabolism and provide new horizons to treat nonalcoholic steatohepatitis. | Metabol Open | 2024 | 38187470 | PubTator, text mining | PubMed |
| omicSynth: An open multi-omic community resource for identifying druggable targets across neurodegenerative diseases. | Am J Hum Genet | 2024 | 38181731 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2053/papers?page=11